Abstract:Abstract Background Glioblastoma multiforme (GBM), a lethal brain tumor, remains the most daunting challenge in cancer therapy. Overexpression and constitutive activation of PDGFs and PDGFRα are observed in most GBM; however, available inhibitors targeting isolated signaling pathways are minimally effective. Therefore, better understanding of crucial mechanisms underlying GBM is needed for developing more effective targeted therapies. Methods Target genes controlled by HIF1α in GBM were identified by analysis of TCGA database and by RNA-sequencing of GBM cells with HIF1α knockout by sgRNA-Cas9 method. Functional roles of HIF1α, PDGFs and PDGFRs were elucidated by loss- or gain-of-function assays or chemical inhibitors, and compared in response to oxygen tension. Pharmacological efficacy and gene expression in mice with intracranial xenografts of primary GBM were analyzed by bioluminescence imaging and immunofluorescence. Results HIF1α binds the PDGFD proximal promoter and PDGFRA intron enhancers in GBM cells under normoxia or mild-hypoxia to induce their expression and maintain constitutive activation of AKT signaling, which in turn increases HIF1α protein level and activity. Paradoxically, severe hypoxia abrogates PDGFRα expression despite enhancing HIF1α accumulation and corresponding PDGF-D expression. Knockout of HIF1A , PDGFD or PDGFRA in U251 cells inhibits cell growth and invasion in vitro and eradicates tumor growth in vivo. HIF1A knockdown in primary GBM extends survival of xenograft mice, whereas PDGFD overexpression in GL261 shortens survival. HIF1α inhibitor Echinomycin induces GBM cell apoptosis and effectively inhibits growth of GBM in vivo by simultaneously targeting HIF1α-PDGFD/PDGFRα-AKT feedforward pathway. Conclusions HIF1α orchestrates expression of PDGF-D and PDGFRα for constitutive activation of AKT pathway and is crucial for GBM malignancy. Therefore, therapies targeting HIF1α should provide an effective treatment for GBM.

Upregulated AHIF-mediated Radioresistance in Glioblastoma.

AHIF Promotes Glioblastoma Progression and Radioresistance Via Exosomes.

Hypoxia-Induced Autophagy Is Involved in Radioresistance via HIF1A-Associated Beclin-1 in Glioblastoma Multiforme

Silencing of HIF-1α Enhances the Radiation Sensitivity of Human Glioma Growth in Vitro and in Vivo.

Suppression of FoxO3a Increases Responsiveness of Glioma Cells to Radiation Treatment

Multiomics analyses reveal DARS1-AS1 /YBX1–controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance

The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin

Silencing Lncrna GIHCG Increases Radiosensitivity of Glioma Cells by Up-Regulating Mir-146A-3p

Linc-RA1 Inhibits Autophagy and Promotes Radioresistance by Preventing H2Bub1/USP44 Combination in Glioma Cells.

Upregulation of DNA Metabolism-Related Genes Contributes to Radioresistance of Glioblastoma.

Knockdown of Nrf2 Suppresses Glioblastoma Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α.

LncRNA RBPMS-AS1 Promotes NRGN Transcription to Enhance the Radiosensitivity of Glioblastoma Through the Microrna-301A-3p/camta1 Axis

LincRNA-p21 Knockdown Enhances Radiosensitivity of Hypoxic Tumor Cells by Reducing Autophagy Through HIF-1/Akt/mTOR/P70S6K Pathway

CircFOXO3 upregulation mediates the radioresistance of glioblastoma by affecting cellular metabolome

Lncrna MAFG‑AS1 Enhances Radioresistance of Glioblastoma Cells Via Mir‑642a‑5p/notch1 Axis

Transcriptome Analysis of Glioma Cells for the Dynamic Response to Γ-Irradiation and Dual Regulation of Apoptosis Genes: a New Insight into Radiotherapy for Glioblastomas.

Knockdown of ATRX enhances radiosensitivity in glioblastoma

Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma

SIRT2 Suppression Increases Responsiveness of Glioma Cells to Radiation Treatment Via FoxO3a Inhibition

ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways

LRIG 1 Enhances the Radiosensitivity of Radioresistant Human Glioblastoma U 251 Cells Via Attenuation of the EGFR / Akt Signaling Pathway